Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hong Kong
Biotech
BioNTech backing powers DualityBio toward $200M Hong Kong IPO
Backers including BioNTech have committed around one-third of the targeted IPO haul, putting DualityBio on course to raise cash for its ADC pipeline.
Nick Paul Taylor
Apr 7, 2025 8:21am
GSK, Merck and Pfizer in Ab&B's sights as biotech files for IPO
Jan 23, 2025 8:01am
BMS, Takeda's Chinese partners file for IPOs
Jan 22, 2025 6:11am
HanxBio plans Hong Kong IPO to fund phase 2 solid tumor trial
Nov 25, 2024 9:20am
Zephyrm seeks Hong Kong IPO to fund phase 3 cell therapy trials
Oct 2, 2024 8:19am
Duality seeks cash for ADC trials as IPO wave spreads to Asia
Aug 27, 2024 9:20am
